HeartSciences Inc.
HSCS
$3.05
$0.0852.87%
10/31/2024 | 07/31/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | -7.59% | 2.04% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -4.37% | 10.42% | |||
Operating Income | 4.37% | -10.42% | |||
Income Before Tax | -1.52% | -11.13% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -1.52% | -11.13% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -1.52% | -11.13% | |||
EBIT | 4.37% | -10.42% | |||
EBITDA | 4.41% | -10.33% | |||
EPS Basic | 13.94% | 6.54% | |||
Normalized Basic EPS | 13.93% | 6.55% | |||
EPS Diluted | 13.94% | 6.54% | |||
Normalized Diluted EPS | 13.93% | 6.55% | |||
Average Basic Shares Outstanding | 17.96% | 18.90% | |||
Average Diluted Shares Outstanding | 17.96% | 18.90% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |